Accessibility Menu
Doximity logo

Doximity(NYSE) DOCS

Market Cap$4.37BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-54%
5 Year-69%
1 Year-62%
1 Month+14%
$25.03
+2.08%
+0.51Today
After hours$24.99-$0.04 (-0.16%)
Doximity last closing stock price
MetricPriceDate
Last closeUSD 24.522026-08-17
Doximity stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.33%USD 25.632026-08-10
1 month+13.94%USD 21.522026-07-17
3 month+27.31%USD 19.262026-05-19
Year to date-44.63%USD 44.282025-12-31
1 year-62.35%USD 65.132025-08-15
3 year+10.1%USD 22.272023-08-18
5 year-68.97%USD 79.022021-08-18
Since inception-53.74%USD 53.002021-06-24

Doximity Financials at a Glance

Market Cap

$4.37BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$655.57M

Net Income (TTM)

$167.05M

EPS (TTM)

$0.84

P/E Ratio

29.08

Dividend

$0.00

Beta (Volatility)

1.42 (Average)

Price

$25.03

Volume

2,980,522.091

Open

$24.94

Previous Close

$24.94

Daily Range

$24.75 - $25.28

52-Week Range

$17.15 - $76.51

Estimated Earnings Date

Nov 5, 2026

About Doximity

Doximity, Inc. helps doctors and medical workers work more effectively. It provides a digital platform for messaging, telehealth, and research. Most U.S. physicians use the service to coordinate patient care.

A Tool for Every Task

  • Marketing Solutions: Subscription service for pharmaceutical companies to share medical content with targeted providers; contributed to a subscription model that generated 93% of revenue in the three months ended June 30, 2026.
  • Workflow Solutions: Digital tools for daily medical tasks including voice calls, secure messaging, and HIPAA-compliant faxing.
  • Hiring Solutions: Platform for healthcare organizations to post job openings and message potential medical recruits.
  • Clinical AI Suite: Documentation and research tools featuring ambient note-taking and generative AI clinical assistants.

Building the Digital Medical Network

  • Launched the Clinical AI Suite to assist with physician documentation and clinical research.
  • Completed a $500 million share repurchase program in the fourth quarter of fiscal year 2026.
  • Authorized a second $500 million share repurchase program on Feb. 3, 2026.
  • Expanded the registered membership to over 3 million medical professionals as of March 31, 2026.

What Sets the Platform Apart

The platform includes over 85% of all U.S. physicians, spanning every medical specialty and all 50 states. Its physician-first design integrates secure communication and AI-powered research tools directly into daily clinical workflows. These tools meet federal HIPAA standards, the Health Insurance Portability and Accountability Act, which protects sensitive patient health information.

The Latest Financial Numbers

  • Revenue reached $156.6 million for the three months ended June 30, 2026, up 7% year over year.
  • Net income was $24.3 million for the three months ended June 30, 2026.
  • Adjusted EBITDA reached $74.8 million for the three months ended June 30, 2026.
  • The company held $687.8 million in cash, cash equivalents, and marketable securities as of June 30, 2026.
  • Net revenue retention rate was 107% for the twelve-month period ended June 30, 2026.

The Bottom Line

Doximity has evolved from a professional networking site into an essential digital toolset for the medical community. By integrating clinical AI and communication tools, the company has solidified its position as a central hub for U.S. healthcare practitioners.

AI Generated • Aug 7, 2026

Industry

Health Care Technology

Employees

880

CEO

Jeffrey A. Tangney, MBA

Headquarters

San Francisco, CA 94107, US

DOCS Financials

Key Financial Metrics (TTM)

Gross Margin

88.07%

Operating Margin

29.60%

Net Income Margin

25.48%

Return on Equity

16.95%

Return on Capital

22.36%

Return on Assets

15.41%

Earnings Yield

3.44%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.37BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

178.25M

Volume

2.98M

Avg. Volume

4.97M

Financials (TTM)

Gross Profit

$577.34M

Operating Income

$194.05M

EBITDA

$243.80M

Operating Cash Flow

$306.34M

Capital Expenditure

-$7.06M

Free Cash Flow

$299.29M

Cash & ST Invst.

$687.79M

Total Debt

$9.67M

Doximity Performance Analysis

Doximity annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 419,052,00022.0%
20242024-03-31USD 475,422,00013.5%
20252025-03-31USD 570,399,00020.0%
20262026-03-31USD 644,863,00013.1%
Doximity sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3015.5%
Q32025-12-319.8%
Q42026-03-31-21.4%
Q12026-06-307.7%
Doximity annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD 0.53-24.1%
20242024-03-31USD 0.7235.7%
20252025-03-31USD 1.1154.6%
20262026-03-31USD 0.98-11.2%
Doximity sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3014.8%
Q32025-12-31N/A
Q42026-03-31-67.7%
Q12026-06-3030.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

$156.62M

+7.3%

Gross Profit

$132.93M

+2.2%

Gross Margin

84.87%

N/A

Market Cap

$4.37BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.97M

N/A

Employees

880

N/A

Net Income

$24.32M

-54.4%

EBITDA

$44.65M

-33.3%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

$687.79M

-18.2%

Total Debt

$9.67M

-18.3%

Accounts Receivable

$177.58M

+25.4%

Inventory

$0.00

N/A

Long Term Debt

$7.53M

-22.1%

Short Term Debt

$2.14M

-1.2%

Return on Assets

15.41%

N/A

Return on Invested Capital

20.79%

N/A

Free Cash Flow

$41.93M

-30.3%

Operating Cash Flow

$41.99M

-32.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HQYHealthEquity, Inc.
$102.79+0.45%
TEMTempus AI, Inc.
$49.36-4.42%
EHCEncompass Health Corporation
$122.10+0.09%
RVTYRevvity, Inc.
$113.75-2.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.48-0.02%
INTCIntel
$96.69-0.07%
NOKNokia
$10.39-0.04%
NVDANvidia
$219.74-0.02%

Questions About DOCS

What is the current price of Doximity?

Doximity is trading at $24.94 per share.

What is the 52-week range for Doximity?

Over the past 52 weeks, Doximity has traded between $17.15 and $76.51.

How much debt does Doximity have?

As of the most recent reporting period, Doximity reported total debt of $9.67M.

How much cash does Doximity have on hand?

Doximity reported $273.60M in cash and cash equivalents in its most recent financial results.

What is Doximity’s dividend yield?

Doximity does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.